Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Aspect Biosystems
company
About
Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
- 51 - 100
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $2.70M
- Industries
- Biotechnology,Life Science
- Founded date
- Nov 19, 2013
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. By combining its proprietary microfluidic 3D bioprinting technology, therapeutic cells, and materials science, Aspect is creating a pipeline of allogeneic cell-based tissue therapeutics to replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2.70M
Aspect Biosystems has raised a total of
$2.70M
in funding over 2 rounds. Their latest funding was raised on
Nov 15, 2018 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 15, 2018 | Grant | $2.70M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Aspect Biosystems is funded by 1 investors.
Western Innovation (WINN) Initiative
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
